Search
Azenta Inc
AZTAAdd to Watchlist
26.060USD
-0.130-0.50%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.50%
5 Days
+9.22%
1 Month
+12.38%
6 Months
-21.65%
Year to Date
-21.65%
1 Year
-17.95%
Key Figures
26.290Open
26.800High
210.11KVolume
LossP/E TTM
42.33P/E Dynamic
--Dividend TTM
0.46%Turnover Ratio
26.190Prev. Close
25.700Low
3.87MTurnover
LossP/E Static
0.77P/B
0.00%Div Yield TTM
-5.62%ROA
41.73052wk High
0.51Volume Ratio
-55.76MNet Profit
46.09MShares
-3.7659EPS TTM
1.40Beta
-6.81%ROE
15.93052wk Low
4.20%Amplitude
-119.86%Gross Margin
1.20BMarket Cap
3.95Reward/Risk
2.98%Risk Rate
TradingKey Stock Score of Azenta Inc
Currency: USD Updated: 2026-07-01Key Insights
Azenta Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Azenta Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Azenta Inc Highlights
StrengthsRisks
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 593.82M.
Overvalued
The company’s latest PE is -6.95, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.28M shares, decreasing 8.52% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 518.28K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.13.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
28.500
Target Price
+11.68%
Upside Space
Azenta Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Azenta Inc Info
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Ticker SymbolAZTA
CompanyAzenta Inc
CEOMarotta (John)
Websitehttps://www.azenta.com/
Related Instruments
+1.33%
+2.83%
+5.32%
+3.44%
+2.26%
+3.06%
+3.01%
+2.95%
+3.47%
+1.82%
+4.20%
+1.56%
+3.97%
+3.16%
+2.05%
0.00%
+3.30%
+3.10%
+0.25%
+4.50%Popular Instruments
52675.900
+421.600 (+0.81%)
29249.900
-549.400 (-1.84%)
7458.200
-17.300 (-0.23%)
14733.000
-622.000 (-4.05%)
67864.000
-1621.000 (-2.33%)
6338.800
+63.400 (+1.01%)
68.534
+0.566 (+0.83%)
308.310
+13.930 (+4.73%)
193.510
-4.070 (-2.06%)
4124.570
+93.800 (+2.33%)
FAQs
What is the current price of Azenta Inc (AZTA)?
The current price of Azenta Inc (AZTA) is 26.19.
What is the symbol of Azenta Inc?
The ticker symbol of Azenta Inc is AZTA.
What is the 52-week high of Azenta Inc?
The 52-week high of Azenta Inc is 41.73.
What is the 52-week low of Azenta Inc?
The 52-week low of Azenta Inc is 15.93.
What is the market capitalization of Azenta Inc?
The market capitalization of Azenta Inc is 1.21B.
Is Azenta Inc (AZTA) currently rated as Buy, Hold, or Sell?
According to analysts, Azenta Inc (AZTA) has an overall rating of Buy, with a price target of 28.50.
What is the Earnings Per Share (EPS TTM) of Azenta Inc (AZTA)?
The Earnings Per Share (EPS TTM) of Azenta Inc (AZTA) is -1.22.